Abcam acquires Ascent for £10 million
This article was originally published in Scrip
Executive Summary
Abcam, a global supplier of protein research tools, is to acquire privately-held Ascent Scientific (UK), a provider of biochemical reagents, for £6 million in cash and £4 million in Abcam shares.